Lista de obras - Carles Pericay - Dominio Público Uruguay

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

artículo científico publicado en 2015

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

artículo científico publicado en 2011

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

artículo científico publicado en 2017

Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status

artículo científico publicado en 2007

Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.

artículo científico publicado en 2017

Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.

artículo científico publicado en 2013

BRCA2 germ-line mutations in Spanish male breast cancer patients

article

BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families

article

Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

artículo científico publicado en 2010

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.

artículo científico publicado en 2015

Clinical and pathological findings of BRCA1/2 associated breast cancer

artículo científico publicado en 2001

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

artículo científico publicado en 2014

Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit

scientific article published on 01 May 2001

Current controversies in the management of metastatic colorectal cancer

artículo científico

Data on individual PCR efficiency values as quality control for circulating miRNAs

artículo científico publicado en 2015

Descripción de una nueva mutación germinal en el gen TP53 en una familia con síndrome de Li-Fraumeni. Asesoramiento clínico a los portadores sanos

scientific article published on 01 October 2002

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

scientific article published on 21 July 2016

Erratum to: SEOM guidelines for the treatment of gastric cancer 2015.

artículo científico publicado en 2016

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

artículo científico publicado en 2015

Extravasation of oxaliplatin: an infrequent and irritant toxicity.

artículo científico publicado en 2009

Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer

artículo científico publicado en 2015

Gastrointestinal stromal tumors

artículo científico publicado en 2006

Hybrid NOTES: TEO for transanal total mesorectal excision: intracorporeal resection and anastomosis.

artículo científico

In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions.

artículo científico publicado en 2009

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.

artículo científico publicado en 2004

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer

artículo científico publicado en 2016

Merkel cell carcinoma associated with a paraneoplastic neurological syndrome.

artículo científico publicado en 2004

Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.

artículo científico publicado en 2016

Microglandular adenosis of the breast in a BRCA1 mutation carrier: radiological features

scientific article published on 14 November 2001

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study

artículo científico publicado en 2013

Neoadjuvant therapy and transanal endoscopic surgery in T2-T3 superficial, N0, M0 rectal tumors. Local recurrence, complete clinical and pathological response

artículo científico publicado en 2017

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.

artículo científico publicado en 2017

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.

artículo científico publicado en 2016

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors

artículo científico publicado en 2012

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).

artículo científico publicado en 2011

Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer

artículo científico publicado en 2013

Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma

artículo científico publicado en 2016

Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial

artículo científico publicado en 2014

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

artículo científico publicado en 2011

Recommendations on current approach to gastric cancer

artículo científico publicado en 2009

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer

artículo científico publicado en 2014

SEOM Clinical Guideline of localized rectal cancer (2016).

artículo científico publicado en 2016

SEOM clinical guidelines for the treatment of oesophageal cancer

artículo científico publicado en 2011

Seom guidelines for the treatment of gastric cancer 2015.

artículo científico publicado en 2015

Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.

artículo científico publicado en 2010

Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer.

artículo científico publicado en 2013

Synchronous isolated adrenal metastasis from rectum adenocarcinoma.

artículo científico publicado en 2009

TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

artículo científico publicado en 2014

Variability in microRNA recovery from plasma: Comparison of five commercial kits.

artículo científico publicado en 2015

[Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer].

artículo científico publicado en 2014

[Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital]

scientific article published on 01 June 2007

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers

artículo científico publicado en 2013

Lista de obras de Carles Pericay

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study

Adherence to capecitabine in preoperative treatment of stage II and III rectal cancer: do we need to worry?

Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status

Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.

Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study.

BRCA2 germ-line mutations in Spanish male breast cancer patients

BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families

Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†.

Clinical and pathological findings of BRCA1/2 associated breast cancer

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

Conditions for single-strand conformation polymorphism (SSCP) analysis of BRCA1 gene using an automated electrophoresis unit

Current controversies in the management of metastatic colorectal cancer

Data on individual PCR efficiency values as quality control for circulating miRNAs

Descripción de una nueva mutación germinal en el gen TP53 en una familia con síndrome de Li-Fraumeni. Asesoramiento clínico a los portadores sanos

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

Erratum to: SEOM guidelines for the treatment of gastric cancer 2015.

Evaluation of efficacy and safety markers in a phase II study of metastatic colorectal cancer treated with aflibercept in the first-line setting

Extravasation of oxaliplatin: an infrequent and irritant toxicity.

Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer

Gastrointestinal stromal tumors

Hybrid NOTES: TEO for transanal total mesorectal excision: intracorporeal resection and anastomosis.

In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions.

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study.

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer

Merkel cell carcinoma associated with a paraneoplastic neurological syndrome.

Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.

Microglandular adenosis of the breast in a BRCA1 mutation carrier: radiological features

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study

Neoadjuvant therapy and transanal endoscopic surgery in T2-T3 superficial, N0, M0 rectal tumors. Local recurrence, complete clinical and pathological response

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors

Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).

Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer

Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma

Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: the GEMCAD 0801 Phase II Multicenter Trial

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

Recommendations on current approach to gastric cancer

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer

SEOM Clinical Guideline of localized rectal cancer (2016).

SEOM clinical guidelines for the treatment of oesophageal cancer

Seom guidelines for the treatment of gastric cancer 2015.

Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.

Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer.

Synchronous isolated adrenal metastasis from rectum adenocarcinoma.

TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.

Variability in microRNA recovery from plasma: Comparison of five commercial kits.

[Cost-effectiveness analysis of aflibercept in combination with FOLFIRI in the treatment of patients with metastatic colorectal cancer].

[Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital]

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers